This cross-sectional study evaluates whether an investigational handheld ultra-widefield optical coherence tomography device without scleral depression can be used to document high-quality images of the peripheral retina for use in retinopathy of prematurity (ROP) examinations.
Visionary News & Insightful Strategy
Footer
A RETINA-SPECIFIC ORGANIZATION
It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.
We’ve got our eyes on working with the best retina groups and vendors in the industry.
See the best; get in touch.
Recent
- Brimochol PF achieves endpoints in second phase 3 presbyopia trial
- Part B of phase 1/2 X-linked retinoschisis gene therapy trial initiated
- VIDEO: OCT advancements allow for measurement of retinal blood flow velocity
- EnVision Summit 2025: Wendy Lee, MD, highlights evolving trends in oculoplastics and aesthetics in program
- Tenpoint Therapeutics announces positive topline results from Phase 3 pivotal trial BRIO-II assessing BRIMOCHOL PF for the treatment of presbyopia
Leave a Reply